NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 5, 2017

Primary Completion Date

January 17, 2018

Study Completion Date

January 18, 2018

Conditions

Asthma

Interventions

DRUG

Indacaterol maleate

150 μg via Concept1 device

DRUG

Indacaterol acetate

150 μg via Concept1 device

DRUG

Placebo

Capsule containing no active ingredients delivered via Concept1 device

Trial Locations (6)

Novartis Investigative Site, Raleigh

Novartis Investigative Site, St Louis

Novartis Investigative Site, El Paso

Novartis Investigative Site, Medford

Novartis Investigative Site, North Dartmouth

Novartis Investigative Site, Skillman